Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Antibody response to Plasmodium vivax in the context of Epstein-Barr virus (EBV) co-infection: A 14-year follow-up study in the Amazon rainforest

PLoS ONE(2025)10.1371/journal.pone.0311704Source: DataRank Database

Antibody response to Plasmodium vivax in the context of Epstein-Barr virus (EBV) co-infection: A 14-year follow-up study in the Amazon rainforest is a research paper published in PLoS ONE (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.02)OA: goldTopics (76)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Bárbara A. Rodrigues,Michelle H. F. Dias,Matheus G. Barcelos ORCID,Maria Fernanda Alves do Nascimento ORCID,Sâmick L. Moreira-Nascimento

Live enrichment

PubMed:39879169 PMC:PMC11778755 OpenAlex:https://openalex.org/W4406953562

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Grant: 422257/2016-8

Fundação de Amparo à Pesquisa do Estado de Minas Gerais

Grant: APQ-02625-15

Fundação Oswaldo Cruz

Grant: VPPCB-007-FIO-18-2-33

NIH Research Project Grant Program

Grant: R01AI064478

National Institutes of Health

Grant: 5R01AI064478-09

Immunological characterization of the P. vivax DBP

FWCI

1.02

Citation Percentile

0.7%

Citation Trend

2025

goldLicense: cc-by

journalhttps://doi.org/10.1371/journal.pone.0311704

publisherhttps://doi.org/10.1371/journal.pone.0311704

publisherhttps://dx.plos.org/10.1371/journal.pone.0311704

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39879169

repositoryhttps://pure.amsterdamumc.nl/en/publications/edc2e126-f0d4-490c-b8d8-61cc23a37eda

Fields of Study

Malaria Research and ControlViral-associated cancers and disordersHematological disorders and diagnostics0303 health sciences03 medical and health sciencesHumansPlasmodium vivaxEpstein-Barr Virus InfectionsFollow-Up StudiesAdultMalaria, VivaxHerpesvirus 4, HumanCoinfectionFemaleMaleAntibodies, ProtozoanRainforestMiddle AgedAdolescentYoung AdultAntibody FormationCross-Sectional StudiesBrazil

MeSH Terms

AdolescentAdultAntibodies, ProtozoanAntibody FormationBrazilCross-Sectional StudiesHerpesvirus 4, HumanFemaleFollow-Up StudiesHumansMaleMiddle AgedPlasmodium vivaxMalaria, VivaxEpstein-Barr Virus InfectionsYoung AdultCoinfectionRainforest

Keywords

VirologyPlasmodium vivaxBiologyMalariaContext (archaeology)ImmunologyAntibodyImmune systemSerostatusAntigenVirusViral loadPlasmodium falciparumAdultMaleEpstein-Barr Virus InfectionsHerpesvirus 4, HumanRainforestAdolescentCoinfectionScienceQRAntibodies, ProtozoanMiddle AgedYoung AdultCross-Sectional StudiesAntibody FormationMalaria, VivaxMedicineHumansFemaleBrazilResearch ArticleFollow-Up Studies

Sustainable Development Goals

SDG 0: Good health and well-being